Tower Research Capital (TRC)’s ASP Isotopes ASPI Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPI
ECA
RIM
ETC
AIC
Tower Research Capital (TRC)'s ASPI Position: Q2 2026 in Review
Tower Research Capital (TRC) reduced its ASP Isotopes (ASPI) stake by 29% in Q2 2026, selling an estimated $28.2K and leaving 11,784 shares worth $73.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2434.
Tower Research Capital (TRC) first reported a position in ASPI in Q3 2023 and has held it in 11 quarters since. The position peaked at $242K in Q3 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.
- Tower Research Capital (TRC) held 11,784 shares of ASP Isotopes worth $73.3K as of Q2 2026.
- Tower Research Capital (TRC) sold 4,794 ASP Isotopes shares in Q2 2026, an estimated $28.2K.
- ASP Isotopes made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2434 holding.
- Tower Research Capital (TRC) first reported a position in ASP Isotopes in Q3 2023 and has held it in 11 quarters since.
- Tower Research Capital (TRC)'s ASP Isotopes position peaked at $242K in Q3 2025.
- 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.